India

INR overview

PairLatest rateToday's change1 year change
INRGBP0.0108
GBP
0.00003 / 0.25%-0.0002 / -1.41%
Today
0.0105Feb 27 20190.012Jul 30 2019
INREUR0.0126
EUR
0.00002 / 0.19%0.0003 / 2.25%
Today
0.012Dec 10 20180.0132Aug 01 2019
INRUSD0.0139
USD
0.00003 / 0.19%-0.00005 / -0.39%
Today
0.0138Dec 10 20180.0146Jul 11 2019
INRJPY1.51
JPY
0.004 / 0.26%-0.0640 / -4.05%
Today
1.46Aug 26 20191.63Dec 03 2018
INRAUD0.0205
AUD
0.00007 / 0.34%0.001 / 5.36%
Today
0.0191Dec 10 20180.0213Aug 02 2019
INRCAD0.0185
CAD
0.00005 / 0.28%-0.0001 / -0.59%
Today
0.0182Nov 19 20190.0197Jan 02 2019
INRCNY0.0981
CNY
0.0003 / 0.30%0.0009 / 0.89%
Today
0.0936Feb 27 20190.1012Sep 27 2019
INRCHF13.84
CHF
0.0614 / 0.45%-0.0849 / -0.61%
Today
13.48Aug 26 201914.75May 03 2019

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of India in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of Oct 16 2019.

Market movers

Constituents of the NX 100 Index - NSE with the highest percent gain over one day.
ListingLastChangeVolume
Vodafone Idea LtdIDEA:NSI7.05
INR
+1.00
+16.53%
1.82bn
Zee Entertainment Enterprises LtdZEEL:NSI307.00
INR
+21.15
+7.40%
32.20m
Sun Pharmaceutical Industries LtdSUNPHARMA:NSI450.00
INR
+24.10
+5.66%
23.11m
Indusind Bank LtdINDUSINDBK:NSI1,469.30
INR
+76.55
+5.50%
7.33m
Bharat Petroleum Corporation LtdBPCL:NSI544.60
INR
+25.65
+4.94%
18.84m
Lupin LtdLUPIN:NSI777.85
INR
+30.15
+4.03%
2.88m
Dr.Reddy's Laboratories LtdDRREDDY:NSI2,838.65
INR
+95.65
+3.49%
997.98k
Dabur India LtdDABUR:NSI468.80
INR
+15.10
+3.33%
2.39m
Aurobindo Pharma LtdAUROPHARMA:NSI444.80
INR
+13.60
+3.15%
5.01m
Yes Bank LtdYESBANK:NSI65.85
INR
+1.70
+2.65%
229.22m
Data delayed at least 15 minutes, as of Nov 20 2019 10:29 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.